The epidemiological and serological characteristics of measles in Dongguan, China, 2005–2014

References

• Simons E, Ferrari M, Fricks J, Wannemuehler K, Anand A, Burton A, Strebel P. Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. Lancet 2012; 379:2173-8; PMID:22534001; http://dx.doi.org/10.1016/S0140-6736(12)60522-4
   PubMed Web of Science ®Google Scholar
• Mulholland EK, Griffith UK, Biellik R. Measles in the 21st century. New Engl J Med 2012; 366:1755-7; PMID:22571199; http://dx.doi.org/10.1056/NEJMp1202396
   PubMed Web of Science ®Google Scholar
• Progress towards regional measles elimination, worldwide, 2000–2014. Wkly Epidemiol Rec 2015; 90(46): 623–31.
   Google Scholar
• Zipprich J, Winter K, Hacker J, Xia D, Watt J, Harriman K. Measles outbreak - California, December 2014- february 2015. MMWR Morb Mortal Wkly Rep 2015; 20(64):153-4
   Google Scholar
• Andrus JK, de Quadros CA, Solórzano CC, Periago MR, Henderson DA. Measles and rubella eradication in the Americas. Vaccine 2011; 29(Suppl 4):D91-6; PMID:22185837; http://dx.doi.org/10.1016/j.vaccine.2011.04.059
   PubMed Web of Science ®Google Scholar
• Durrheim DN, Crowcroft NS, Strebel PM. Measles - The epidemiology of elimination. Vaccine 2014; 5(32):6880-3; PMID:25444814; http://dx.doi.org/10.1016/j.vaccine.2014.10.061
   PubMed Web of Science ®Google Scholar
• Li L, Wenzhou Y, Tiejun S, Chao M, Ning W, Xiaofeng L. Analysis on epidemiological characteristics of age distribution of measles in China during 2003–2006. Chin J Vaccin Immuni 2007; 13:101-5
   Google Scholar
• Lixia W, Guang Z, Lee LA, Zhiwei Y, Jingjin Y, Jun Z, Xiaofeng L, Chang X, Huqun B. Progress in accelerated measles control in the People's Republic of China, 1991–2000. J Infect Dis 2003; 187:S252-7; PMID:12721922; http://dx.doi.org/10.1086/368045
   PubMedGoogle Scholar
• Ma C, An Z, Hao L, Cairns KL, Zhang Y, Ma J, Cao L, Wen N, Xu W, Liang X, et al. Progress toward measles elimination in the People's Republic of China, 2000–2009. J Infect Dis 2011; 204:S447-54; PMID:21666198; http://dx.doi.org/10.1093/infdis/jir103
   PubMedGoogle Scholar
• WHO. Field guidelines for measles elimination; 2004. Available at: http://116.199.115.30/files/1174000003607B13/www.wpro.who.int/publications/docs/FieldGuidelines_for_MeaslesElimination_0F24.pdf
   Google Scholar
• World Health Organization. Measles fact sheet; 2016. Available at: http://www.who.int/mediacentre/factsheets/fs286/en/
   Google Scholar
• Standing Committee of the People's Republic of China. Law of the People's Republic of China on prevention and treatment of infectious diseases. n.d. Available at: http://www.gov.cn/gongbao/content/2004/content_62975.htm
   Google Scholar
• Yongzhen X, Dong W, Weiyan L, Hao T, Shaoli C, Jindong N. Age-related changes in serological susceptibility patterns to measles Results from a seroepidemiological study in Dongguan. China Human Vaccines Immunotherap 2014; 10(4):1097-103; PMID:24448194
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO-recommended standards for surveillanceof selected vaccine-preventable diseases. Geneva, Switzerland: World Health Organization; 2003.
   Google Scholar
• Zhang X, Shirayama Y, Zhang Y, Ba W, Ikeda N, Mori R, Shibuya K. Duration of maternally derived antibody against measles: a seroepidemiological study of infants aged under 8 months in Qinghai, China. Vaccine 2012; 30:752-7; PMID:22133513; http://dx.doi.org/10.1016/j.vaccine.2011.11.078
   PubMed Web of Science ®Google Scholar
• Xianghuan M, Jianmeng Z, Wenwei C. Survey on measles vaccine coverage in the measles supplemental immunization activities in 2010, in Dongguan. Srait J Prev Med 2011; 17:33-4
   Google Scholar
• Goodson JL, Masresha BG, Wannemuehler K, Uzicanin A, Cochi S. Changing epidemiology of measles in Africa. J Infect Dis 2011; 204:S205-14; PMID:21666163; http://dx.doi.org/10.1093/infdis/jir129
   PubMed Web of Science ®Google Scholar
• Jasem J, Marof K, Nawar A, Monirul Islam KM. Epidemiological analysis of measles and evaluation of measles surveillance system performance in Iraq, 2005–2010. Int J Infect Dis 2012; 16:e166–71; PMID:22192582; http://dx.doi.org/10.1016/j.ijid.2011.11.002
   PubMedGoogle Scholar
• Cottrell S, Roberts RJ. Measles outbreak in Europe. Brit Med J 2011; 342:d3724; PMID:21677008; http://dx.doi.org/10.1136/bmj.d3724
   PubMedGoogle Scholar
• Slifka MK, Homann D, Tishon A, Pagarigan R, Oldstone MB. Measles virus infection results in suppression of both innate and adaptive immune responses to secondary bacterial infection. J Clin Invest 2003; 111:805-10; PMID:12639986; http://dx.doi.org/10.1172/JCI13603
   PubMed Web of Science ®Google Scholar
• Beckford AP, Kaschula RO, Stephen C. Factors associated with fatal cases of measles: a retrospective autopsy study. South African Med J 1985; 68:858-63; PMID:3877996
   PubMed Web of Science ®Google Scholar
• Jiujun L, Ying Z, Zhe Liu, Tao Z, Chunfeng L, Xin L. Clinical report of serious complications associated with measles pneumonia in children hospitalized at Shengjing hospital, China. J Infect Dev Ctries 2015; 9:1139-46; PMID:26517490
   PubMed Web of Science ®Google Scholar
• Guo B. Challenges, opportunities, and strategies on China immunization program. Chinese J Vaccines Immun 2006; 12:415-419
   Google Scholar
• Ke H, Huizhen Z, Zhixiong H, Quan Q, Hong Z, Banghua C, Xu J. Vaccination coverage and its determinants among migrant children in Guangdong, China. BMC Public Health 2014; 14:203; PMID:24568184; http://dx.doi.org/10.1186/1471-2458-14-203
   PubMed Web of Science ®Google Scholar
• Lin W, Xiong Y, Tang H, Chen B, Ni J. Factors associated with delayed measles vaccination among children in Shenzhen, China: a case-control study. Hum Vaccin Immunother 2014; 10:3601-6; PMID:25668667; http://dx.doi.org/10.4161/21645515.2014.979687
   PubMed Web of Science ®Google Scholar
• Manikkavasagan G, Ramsay M. Protecting infants against measles in England and Wales: a review. Archives Dis Childhood 2009; 94:681-5; PMID:19457878; http://dx.doi.org/10.1136/adc.2008.149880
   PubMed Web of Science ®Google Scholar
• Leuridan E, Hens N, Hutse V, Ieven M, Aerts M, Van Damme P. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. Brit Med J 2010; 340:c1626; PMID:20483946; http://dx.doi.org/10.1136/bmj.c1626
   PubMed Web of Science ®Google Scholar
• Baba UA, Ashir GM, Mava Y, Elechi HA, Saidu G, Kaleb AA. Transplacental transfer of macromolecules: proving the efficiency of placental transfer of maternal measles antibodies in mother: infant Pairs. Ann Med Health Sci Res 2014; 4(3):298-301; PMID:25364605; http://dx.doi.org/10.4103/2141-9248.141975
   PubMedGoogle Scholar
• Peter A, Cesário LM, May-Lill G, Andreas A, Ane BF, Mogens HC, Ravn H, Rodrigues A, Whittle HC, Benn CS. Measles vaccination in the presence or absence of maternal measles antibody: impact on child survival. Clin Infect Dis 2014; 59:484-92; PMID:24829213; http://dx.doi.org/10.1093/cid/ciu354
   PubMed Web of Science ®Google Scholar
• Hartter HK, Oyedele OI, Dietz K, Kreis S, Hoffman JP, Muller CP. Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children. Pediatr Infect Dis J 2000; 19:635-41; PMID:10917222; http://dx.doi.org/10.1097/00006454-200007000-00010
   PubMed Web of Science ®Google Scholar
• Nicoara C, Zäch K, Trachsel D, Germann D, Matter L. Decay of passively acquired maternal antibodies against measles, mumps, and rubella viruses. Clin Diagn Lab Immunol 1999; 6:868-71; PMID:10548578
   PubMedGoogle Scholar
• Xiaohua Z, Xiaolin Z, Bin L. Analysis of antibody level to measles in mothers and their infants. Chin J Health Lab Technol 2008; 18(6):1143-4
   Google Scholar
• Xu GZ, Ma R, Xu HJ, Ma YH, Dong HJ, Li Y, Hu FX, Ni HX, Bian GL, Liang Y, et al. Levels of transition on maternal transferred measles antibody in infants in 3 cities in China. Zhonghua Liu Xing Bing Xue Za Zhi 2008; 29:1074-7; PMID:19173926
   PubMedGoogle Scholar
• Rui M, Guozhang X, Hongjun D. Maternal-infant pairs comparative study on the change of maternal transferred measles antibody level in infants. Chin J Public Health 2008; 24:747-8
   Google Scholar
• Weisheng L, Ruiheng X, Xiaoping S, Xinge Y. Epidemiological analysis and control strategies of measles in guangdong province. S China J Prev Med 2002; 28:17-21
   Google Scholar
• Chen CJ, Lee PI, Hsieh YC, Chen PY, Ho YH, Chang CJ, Liu DP, Chang FY, Chiu CH, Huang YC, et al. Waning population immunity to measles in Taiwan. Vaccine 2012; 30:6721-7; PMID:22634294; http://dx.doi.org/10.1016/j.vaccine.2012.05.019
   PubMed Web of Science ®Google Scholar
• Xinwei Z, Yoshihisa S, Yongji Z, Wensheng B, Nayu I, Rintaro M, Shibuya K. Duration of maternally derived antibody against measles: A seroepidemiological study of infants aged under 8 months in Qinghai, China. Vaccine 2012; 30:752-7; PMID:22133513; http://dx.doi.org/10.1016/j.vaccine.2011.11.078
   PubMed Web of Science ®Google Scholar
• Kumar ML, Johnson CE, Chui LW, Whitwell JK, Staehle B, Nalin D. Immune response to measles vaccine in 6-month-old infants of measles seronegative mothers. Vaccine 1998; 16:2047-51; PMID:9796063; http://dx.doi.org/10.1016/S0264-410X(98)00083-8
   PubMed Web of Science ®Google Scholar
• Janaszek W, Slusarczyk J. Immunity against measles in populations of women and infants in Poland. Vaccine 2003; 21:2948-53; PMID:12798638; http://dx.doi.org/10.1016/S0264-410X(03)00113-0
   PubMed Web of Science ®Google Scholar
• Gagneur A, Pinquier D. Early waning of maternal measles antibodies: why immunization programs should be adapted over time. Expert Rev Anti Infect Ther 2010; 8:1339-43; PMID:21133659; http://dx.doi.org/10.1586/eri.10.126
   PubMed Web of Science ®Google Scholar
• Aaby P, Martins CL, Ravn H, Rodrigues A, Whittle HC, Benn CS. Is early measles vaccination better than later measles vaccination? Trans R Soc Trop Med Hyg 2015; 109:16-28; PMID:25573106; http://dx.doi.org/10.1093/trstmh/tru174
   PubMed Web of Science ®Google Scholar
• Gans HA, Arvin AM, Galinus J, Logan L, DeHovitz R, Maldonado Y. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA 1998; 280:527-32; PMID:9707142; http://dx.doi.org/10.1001/jama.280.6.527
   PubMed Web of Science ®Google Scholar